Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience.
Chitanava T, Matvienko I, Shuvaev V, Voloshin S, Martynkevich I, Vlasova Y, Efremova E, Mileeva E, Pirkhalo A, Makarova T, Vlasik R, Karyagina E, Il Ina N, Medvedeva N, Dorofeeva N, Shneider T, Siordiya N, Kulemina O, Sbityakova E, Lazorko N, Alexeeva J, Motorin D, Morozova E, Lomaia E.
Chitanava T, et al. Among authors: motorin d.
Front Oncol. 2023 Mar 16;13:1138683. doi: 10.3389/fonc.2023.1138683. eCollection 2023.
Front Oncol. 2023.
PMID: 37007128
Free PMC article.